Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Core Molding TechnologiesCMT +0.50%49 EBITDA Margin % is 8.90% as of Jun. 2026, which is 5% below its 10-year median of 9.36. GuruFocus rates CMT with a GF Score™ of 49/100 and a GF Value™ of $14.89 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 1,583 Chemicals companies, Core Molding Technologies ranks worse than 56.6% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Core Molding Technologies EBITDA Margin % Related Terms
Core Molding Technologies EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Core Molding Technologies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Core Molding Technologies EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Core Molding Technologies's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Core Molding Technologies's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Core Molding Technologies (CMT) has a EBITDA Margin % of 8.90% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Core Molding Technologies and its competitors. This is near median its historical median of 9.36. According to the industry distribution chart, Core Molding Technologies ranks #896 out of 1583 companies in the Chemicals industry, placing it in the top 56.6%.
Is Core Molding Technologies' EBITDA Margin % too high?
Core Molding Technologies' current EBITDA Margin % of 8.90% is near median its 10-year median of 9.36. The Chemicals industry median EBITDA Margin % is 10.25. Core Molding Technologies' value of 8.90% is 13.2% below this industry median. Based on the distribution chart, Core Molding Technologies ranks #896 out of 1583 companies in the Chemicals industry, which is below the industry midpoint. Overall, Core Molding Technologies has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Core Molding Technologies' EBITDA Margin % compare to FF and HDSN?
According to the Chemicals industry distribution chart, Core Molding Technologies ranks #896 out of 1583 companies for EBITDA Margin %. This places Core Molding Technologies in the lower half of its industry. The industry median EBITDA Margin % is 10.25. Core Molding Technologies' value of 8.90% is 13.2% below this benchmark. While the company's 10-year median is 9.36 vs. the industry median of 10.25, Core Molding Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 10.25, based on 1,583 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Core Molding Technologies's current EBITDA Margin % of 8.90% is 13.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Core Molding Technologies and its competitors. For the Chemicals industry, the median EBITDA Margin % is 10.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Core Molding Technologies's current EBITDA Margin % is 8.90%, which is near median its own 10-year median of 9.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Core Molding Technologies stock overvalued right now?
Based on GuruFocus' analysis, Core Molding Technologies (CMT) is currently considered Significantly Overvalued. The stock's GF Value™ is $14.89, compared to a current price of $26.23 — trading 76.2% above its estimated fair value. The current EBITDA Margin % is 8.90%, which is near median its 10-year median of 9.36 and 13.2% below the Chemicals industry median of 10.25. Core Molding Technologies' overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Core Molding Technologies (CMT), the current EBITDA Margin % is 8.90% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Core Molding Technologies (CMT) Overvalued in 2026?
Based on GuruFocus' analysis, Core Molding Technologies stock appears to be overvalued.
The current stock price of $26.23 is trading 76.2% above its estimated GF Value™ of $14.89.
GuruFocus considers Core Molding Technologies to be Significantly Overvalued.
Key valuation signals for CMT:
EBITDA Margin %: 8.90% (near median its 10-year median of 9.36)
GF Value™: $14.89 vs. price of $26.23 (76.2% above fair value)
Industry Position: 13.2% below the Chemicals median (#896 of 1583)
No single metric tells the full story. See the CMT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Core Molding Technologies Inc operates in the engineered materials market as one operating segment as a molder of thermoplastic and thermoset structural products. It produces and sells molded products for varied markets, including medium and heavy-duty trucks, automobiles, power sports, construction and agriculture, building products, and other industrial markets. The processes include compression molding of sheet molding compound (SMC), resin transfer molding (RTM), liquid molding of dicyclopentadiene (DCPD), spray-up and hand-lay-up, direct long-fiber thermoplastics (D-LFT) and structural foam and structural web injection molding (SIM). It operates operates in Columbus, Ohio; Gaffney, South Carolina; Winona, Minnesota; Matamoros and Escobedo, Mexico; and Cobourg, Ontario, Canada.
49GF Score
Get the complete analysis for CMT
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CMT has been successfully added to your 
